Whitehawk Therapeutics (WHWK)

• Market cap: $113M
• 1 day: 1.69%
• 5 days: -5.14%
• 1 month: 13.21%
• 3 months: 23.08%
• 6 months: 17.65%
• Year to date: -23.57%
• 1 year: 0.84%
• 5 years: -84.76%
• 10 years: -95.9%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 22